Breaking News Instant updates and real-time market news.

FATE

Fate Therapeutics

$12.47

0.14 (1.14%)

16:12
11/21/18
11/21
16:12
11/21/18
16:12

Fate Therapeutics files automatic mixed securities shelf

  • 27

    Nov

  • 30

    Nov

  • 01

    Dec

FATE Fate Therapeutics
$12.47

0.14 (1.14%)

09/18/18
PIPR
09/18/18
NO CHANGE
Target $25
PIPR
Overweight
Fate Therapeutics price target raised to $25 from $20 at Piper Jaffray
After Fate Therapeutics announced a collaboration with ONO Pharmaceutical for the joint development and commercialization of two off-the-shelf CAR-T cell product candidates, Piper Jaffray analyst Edward Tenthoff said he likes the deal as it expands Fate's iPSC CAR-T pipeline while also giving the company $70M in near-term funding. Following the collaboration pact, Tenthoff increased his price target on Fate shares to $25 and reiterated an Overweight rating.
09/25/18
PIPR
09/25/18
NO CHANGE
Target $23
PIPR
Overweight
Fate Therapeutics price target lowered to $23 from $25 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff lowered his price target for Fate Therapeutics to $23 to account for dilution from the equity issuance. He estimates Fate now holds proforma cash of $223M to advance and expand its clinical pipeline of off-the-shelf Natural Killer cell and CAR-T therapies. The analyst reiterates an Overweight rating on the shares.
11/05/18
JEFF
11/05/18
INITIATION
Target $17
JEFF
Buy
Fate Therapeutics initiated with a Buy at Jefferies
Jefferies analyst Biren Amin started Fate Therapeutics with a Buy rating and $17 price target. Natural killer cells possess advantageous cytotoxic properties distinct from T cells, and have demonstrated clinical efficacy against select cancer types, Amin tells investors in a research note. The analyst says Fate "offers a unique and potentially disruptive approach."
11/11/18
PIPR
11/11/18
NO CHANGE
Target $23
PIPR
Overweight
Fate Therapeutics' NK100 update at SITC 'encouraging,' says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff notes that Fate Therapeutics updated Phase I NK100 data and provided new details on iPSC platform expansion at SITC. NK100 activity was observed in 7/14 AML, ovarian cancer and solid tumor patients, with seven patients receiving two infusions with NK100 cell persistence through Day 21 without compromised cytotoxicity or viability, he added, highlighting that NK100 is safe with no cytokine release syndrome or neurotoxicity even after multiple doses. Tenthoff is most excited for Fate's transformative iPSC platform enabling unprecedented scalable and homogeneous manufacturing. As expected, Fate found no adventitious agents and expects the first-ever IND on iPSC-derived Natural Killer cell therapy FT500 to clear by year-end 2018, he contends. Tenthoff adds that the company is developing a pipeline of iPSC cell therapies and will file an IND on FT516 by year-end 2018. He reiterates an Overweight rating and $23 price target on the shares.

TODAY'S FREE FLY STORIES

PCG

PG&E

$18.98

-0.475 (-2.44%)

15:49
03/19/19
03/19
15:49
03/19/19
15:49
Hot Stocks
PG&E extends shareholder proposal deadline to March 25 »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZZA

Papa John's

$47.10

-0.2 (-0.42%)

15:41
03/19/19
03/19
15:41
03/19/19
15:41
Periodicals
Breaking Periodicals news story on Papa John's »

Hedgeye adds Papa…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

PVTL

Pivotal Software

$20.01

0.33 (1.68%)

15:38
03/19/19
03/19
15:38
03/19/19
15:38
Conference/Events
Pivotal Software management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

RTIX

RTI Surgical

$5.92

-0.04 (-0.67%)

15:38
03/19/19
03/19
15:38
03/19/19
15:38
Hot Stocks
Glen Capital Partners reports 7.09% passive stake in RTI Surgical »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 28

    May

NAV

Navistar

$32.95

0.26 (0.80%)

15:37
03/19/19
03/19
15:37
03/19/19
15:37
Conference/Events
Navistar management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

AUPH

Aurinia Pharmaceuticals

$6.44

0.17 (2.71%)

15:34
03/19/19
03/19
15:34
03/19/19
15:34
Options
Aurinia Pharmaceuticals options imply 15.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

FB

Facebook

$161.69

1.23 (0.77%)

15:32
03/19/19
03/19
15:32
03/19/19
15:32
Hot Stocks
Facebook settles discriminatory advertising lawsuits »

Facebook COO Sheryl…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

LXRX

Lexicon

$7.79

0.18 (2.37%)

15:30
03/19/19
03/19
15:30
03/19/19
15:30
Options
Call buyer opens a bullish position in Lexicon Pharmaceuticals upside calls »

Call buyer opens a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 25

    Apr

HRTX

Heron Therapeutics

$24.70

0.28 (1.15%)

15:20
03/19/19
03/19
15:20
03/19/19
15:20
Options
6X average daily option volume in Heron Therapeautics driven by call spreads »

6X average daily option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

HNP

Huaneng Power

$23.42

-0.47 (-1.97%)

15:19
03/19/19
03/19
15:19
03/19/19
15:19
Downgrade
Huaneng Power rating change  »

Huaneng Power downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMAR

Smartsheet

$43.88

0.21 (0.48%)

15:19
03/19/19
03/19
15:19
03/19/19
15:19
Options
Smartsheet options imply 12.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 05

    Apr

VALE

Vale

$13.90

0.62 (4.67%)

15:18
03/19/19
03/19
15:18
03/19/19
15:18
Hot Stocks
Vale reports reestablishment of Guaiba Island Terminal activities »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
03/19/19
03/19
15:17
03/19/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
03/19/19
03/19
15:16
03/19/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$23.24

0.54 (2.38%)

15:10
03/19/19
03/19
15:10
03/19/19
15:10
Conference/Events
Mallinckrodt management to meet with Mizuho »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

SYMC

Symantec

$23.27

0.19 (0.82%)

15:10
03/19/19
03/19
15:10
03/19/19
15:10
Options
Put buyers sizing up new positions in Symantec far downside strikes »

Put buyers sizing up new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

GATX

GATX

$76.90

0.21 (0.27%)

15:08
03/19/19
03/19
15:08
03/19/19
15:08
Conference/Events
GATX management to meet with Mizuho »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 26

    Mar

BA

Boeing

$375.00

2.9 (0.78%)

15:08
03/19/19
03/19
15:08
03/19/19
15:08
Periodicals
DOT asks department watchdog to audit approval of Boeing 737, Bloomberg says »

Transportation Secretary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

BA

Boeing

$375.07

2.97 (0.80%)

15:05
03/19/19
03/19
15:05
03/19/19
15:05
Periodicals
Breaking Periodicals news story on Boeing »

DOT asks Inspector…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 28

    May

TME

Tencent Music

$19.33

0.2 (1.05%)

15:04
03/19/19
03/19
15:04
03/19/19
15:04
Options
Tencent options imply 12.9% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

NAII

Natural Alternatives International

$11.20

-0.17 (-1.50%)

15:01
03/19/19
03/19
15:01
03/19/19
15:01
Hot Stocks
Natural Alternatives says Court of Appeals rules in its favor in patent suit »

Natural Alternatives…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
03/19/19
03/19
15:00
03/19/19
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

KEM

Kemet

$18.34

0.02 (0.11%)

14:56
03/19/19
03/19
14:56
03/19/19
14:56
Conference/Events
Kemet management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

DBD

Diebold

$11.07

-0.33 (-2.89%)

14:55
03/19/19
03/19
14:55
03/19/19
14:55
Options
Diebold put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$25.68

2.43 (10.45%)

, GOOG

Alphabet

$1,195.81

12.15 (1.03%)

14:54
03/19/19
03/19
14:54
03/19/19
14:54
Hot Stocks
AMD says Radeon GPUs being used for Google Stadia platform »

AMD (AMD) announced that…

AMD

AMD

$25.68

2.43 (10.45%)

GOOG

Alphabet

$1,195.81

12.15 (1.03%)

GOOGL

Alphabet Class A

$1,199.72

11.63 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.